Company Overview - Onto Innovation (ONTO) ended the recent trading session at $96.95, showing a -1.77% change from the previous day's closing price, which is less than the S&P 500's daily loss of 0.01% [1] - Prior to today's trading, shares of Onto Innovation had gained 1.78%, lagging behind the Computer and Technology sector's gain of 7.44% and the S&P 500's gain of 5.37% [1] Financial Performance - Onto Innovation is projected to report earnings of $1.27 per share, representing a year-over-year decline of 3.79%, with a consensus estimate for revenue of $249.75 million, up 3.06% from the prior-year quarter [2] - Full-year Zacks Consensus Estimates call for earnings of $5.14 per share and revenue of $994.52 million, indicating year-over-year changes of -3.75% and +0.73%, respectively [3] Analyst Insights - Recent revisions to analyst forecasts for Onto Innovation are important as they reflect changing business trends, with positive alterations indicating analyst optimism regarding the business and profitability [3] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Onto Innovation at 3 (Hold), with the Zacks Consensus EPS estimate remaining stagnant over the past month [5] Valuation Metrics - Onto Innovation has a Forward P/E ratio of 19.22, which shows no noticeable deviation compared to its industry's Forward P/E of 19.22 [6] - The company has a PEG ratio of 0.64, indicating a favorable valuation relative to its expected earnings growth rate, consistent with the average PEG ratio of nanotechnology stocks [7] Industry Context - The Nanotechnology industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 92, placing it in the top 38% of all 250+ industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Core Viewpoint - FendX Technologies Inc. has completed debt settlements to improve its financial position by reducing existing liabilities, issuing shares and units to settle a total of $629,338.20 in debt [1][3][4] Debt Settlements - The company issued 1,249,024 common shares at $0.082 per share to settle $102,420 of debt [1] - Additionally, 8,781,969 units were issued at $0.06 per unit to settle $526,918.20 of debt, with each unit consisting of one share and one transferable warrant [1][2] - The warrants allow holders to acquire additional shares at $0.10 for 36 months, with potential acceleration of expiry if share prices exceed $0.20 for 20 consecutive trading days [2] Financial Position Improvement - The debt settlements are aimed at enhancing the company's financial health by reducing liabilities [3] - The securities issued are subject to a hold period of four months and one day from the issuance date [3] Related Party Transactions - Two insiders participated in the debt settlements, settling a total of $435,043.20 in debt, classified as related party transactions [4] - The company is relying on exemptions from formal valuation and minority approval requirements due to the fair market value of the settlements being less than 25% of its market capitalization [4] Product Development - FendX is developing REPELWRAP™ film, a protective surface coating that reduces pathogen adhesion by over 98%, with potential applications in healthcare and other industries [6][7] - The company is also advancing an eco-friendly smart sponge and specialized catheter coatings, holding exclusive agreements and licenses for its technologies [7]

Industry Trend - Nanotechnology's initial promise of molecule-size factories is making a comeback [1] - Nanotechnology, once considered a marketing gimmick, is now experiencing a resurgence [1]

Nanotechnology & AI - AI is being used in new ways to enable nanotechnology's potential [1] - Nanotechnology applications include disease treatment, drug testing, and boosting crop yields [1]

Nanotechnology & AI Solutions - Nanotechnology offers solutions to global challenges, especially regarding AI's societal threats [1] - Interdisciplinary approach combining neuroscience and nanoelectronics is key [1] Expert Profile - Mark Hersam is a nanotechnologist at Northwestern University [1] - Hersam's research spans nanomaterials, additive manufacturing, nanoelectronics, renewable energy, and quantum information science [1] Achievements & Recognition - Hersam received the Marshall Scholarship, Presidential Early Career Award for Scientists and Engineers, American Vacuum Society Medard Welch Award, U S Science Envoy, and MacArthur Fellowship [1] - Hersam is a member of the American Academy of Arts and Sciences, National Academy of Engineering, and National Academy of Inventors [1] Entrepreneurial Ventures - Hersam founded NanoIntegris and Volexion [1] - NanoIntegris supplies nanoelectronic materials [1] - Volexion supplies battery materials [1]

Core Viewpoint - Xeriant, Inc. has successfully completed an 80-minute internal fire test for its NEXBOARD™ nanotechnology-based fire retardant, marking a significant milestone towards commercial production [1][2][3] Group 1: Product Development - The 80-minute fire test was conducted under controlled lab conditions, designed to exceed extreme fire exposure scenarios for certification [2] - Xeriant's proprietary fire-retardant formulation utilizes nanotechnology to create a chemically stable, heat-resistant barrier without toxic halogens or heavy metals [2][3] - NEXBOARD is an eco-friendly construction panel intended to replace traditional materials like drywall, OSB, and plywood, offering superior durability against fire, water, mold, insects, cracking, and abrasion [4][6] Group 2: Market Positioning - As fire safety regulations tighten across industries, Xeriant aims to position itself as a leader in sustainable fireproofing technologies [4] - The successful test results bring the company closer to delivering a commercially viable solution that meets the global demand for non-toxic, fire-resistant building products [3][4]

PARIS and CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ''Company''), a late-clinical stage biotechnology company pioneering nanoparticle- based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conference: Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches ...

Group 1 - LiqTech International, Inc. will report its first quarter 2025 financial results on May 14, 2025, before the market opens [1] - A conference call to review the results is scheduled for the same day at 9:00 a.m. Eastern time [1][2] - The conference call can be accessed via phone or a live webcast on the company's website [2] Group 2 - LiqTech International, Inc. specializes in high-tech filtration products and systems, particularly ceramic silicon carbide filtration technologies for gas and liquid purification [4] - The company's silicon carbide membranes are designed for challenging purification applications, including controlling diesel exhaust soot emissions [4] - LiqTech utilizes nanotechnology to develop a range of filtration products, offering unique turnkey solutions for water purification [4]

Company Performance - Onto Innovation (ONTO) closed at $122.28, reflecting a -1.96% change from the previous day, underperforming the S&P 500's gain of 0.58% [1] - Over the past month, Onto Innovation's shares have increased by 2.79%, outperforming the Computer and Technology sector's gain of 0.6% and the S&P 500's loss of 0.84% [1] Upcoming Earnings - The company's earnings report is scheduled for May 8, 2025, with an expected EPS of $1.47, indicating a 24.58% increase from the same quarter last year [2] - The Zacks Consensus Estimate for revenue is projected at $264.96 million, up 15.78% from the previous year [2] Fiscal Year Estimates - For the entire fiscal year, the Zacks Consensus Estimates predict earnings of $6.09 per share and revenue of $1.07 billion, reflecting increases of +14.04% and +8.62% respectively from the prior year [3] Analyst Estimates - Recent changes in analyst estimates for Onto Innovation are crucial as they reflect short-term business trends, with positive revisions indicating analyst optimism about the company's profitability [4] - The Zacks Consensus EPS estimate has decreased by 3.21% in the past month, and Onto Innovation currently holds a Zacks Rank of 4 (Sell) [6] Valuation Metrics - Onto Innovation is trading at a Forward P/E ratio of 20.5, which is in line with the industry's average [7] - The company has a PEG ratio of 0.68, indicating a favorable valuation relative to its expected earnings growth [7] Industry Context - The Nanotechnology industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 240, placing it in the bottom 4% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Core Insights - Intel reported strong first-quarter 2025 results, beating estimates for both earnings and revenues, but provided a downbeat outlook for the ongoing quarter, leading to a 5.1% drop in shares during aftermarket hours [1][3]. Financial Performance - Earnings per share for Q1 2025 were 13 cents, exceeding the Zacks Consensus Estimate by 12 cents, but down from 18 cents in the previous year [3]. - Revenues remained flat year-over-year at $12.67 billion, surpassing the estimated $12.32 billion [3]. - Data center and AI revenues grew by 8%, while Intel Foundry revenues increased by 7%, but client computing revenues declined by 8% [3]. Future Outlook - For the current quarter, Intel projects revenues between $11.2 billion and $12.4 billion, below the Zacks Consensus Estimate of $12.84 billion [4]. - Adjusted earnings are expected to break even, significantly lower than the Zacks Consensus Estimate of 6 cents [4]. - The softer guidance is attributed to tariffs impacting demand and supply chains [4]. Strategic Initiatives - CEO Lip-Bu Tan, appointed in March 2025, is implementing significant changes to revitalize Intel's performance, including flattening the corporate hierarchy and reducing bureaucracy [5][6]. - Plans include cutting more than 20% of the workforce and implementing a mandatory four-day in-office workweek starting September 1, 2025, to enhance collaboration [5]. - The new CEO targets $500 million in operating expense reductions for 2025 and an additional $2 billion in capital expenditure cuts [5]. ETFs with Intel Exposure - REX FANG & Innovation Equity Premium Income ETF (FEPI) holds Intel at a 6.8% share, with AUM of $390.1 million and an average daily volume of 167,000 shares [7]. - ProShares Nanotechnology ETF (TINY) has Intel at a 5.4% share, with AUM of $4.3 million and an average daily volume of 1,000 shares [8]. - Xtrackers Semiconductor Select Equity ETF (CHPS) lists Intel as the top firm with a 5.2% share, managing $5.8 million in assets [9][10]. - Themes Generative Artificial Intelligence ETF (WISE) includes Intel at a 4.8% share, with AUM of $22.8 million [11]. - VanEck Vectors Semiconductor ETF (SMH) has Intel accounting for 4.1% of its holdings, with managed assets of $17.3 billion and an average daily volume of 8.5 million shares [12].